ACCOLADE INC (ACCD)
US00437E1029 - Common Stock
We assign a fundamental rating of 3 out of 10 to ACCD. ACCD was compared to 107 industry peers in the Health Care Providers & Services industry. While ACCD seems to be doing ok healthwise, there are quite some concerns on its profitability. ACCD is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ACCD had negative earnings in the past year.
In the past year ACCD had a positive cash flow from operations.
In the past 5 years ACCD always reported negative net income.
In the past 5 years ACCD always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -10.59%, ACCD is doing worse than 70.48% of the companies in the same industry.
ACCD has a worse Return On Equity (-18.93%) than 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.59% | ||
| ROE | -18.93% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ACCD has a better Gross Margin (48.24%) than 76.19% of its industry peers.
In the last couple of years the Gross Margin of ACCD has grown nicely.
ACCD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
2. Health
2.1 Basic Checks
ACCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ACCD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ACCD has an Altman-Z score of -0.60. This is a bad value and indicates that ACCD is not financially healthy and even has some risk of bankruptcy.
ACCD has a Altman-Z score of -0.60. This is amonst the worse of the industry: ACCD underperforms 81.90% of its industry peers.
ACCD has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
ACCD's Debt to Equity ratio of 0.49 is fine compared to the rest of the industry. ACCD outperforms 60.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.6 |
ROIC/WACCN/A
WACC7.6%
2.3 Liquidity
A Current Ratio of 2.72 indicates that ACCD has no problem at all paying its short term obligations.
ACCD has a Current ratio of 2.72. This is amongst the best in the industry. ACCD outperforms 85.71% of its industry peers.
A Quick Ratio of 2.72 indicates that ACCD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.72, ACCD belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.72 | ||
| Quick Ratio | 2.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.63% over the past year.
The Revenue has grown by 16.04% in the past year. This is quite good.
ACCD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.31% yearly.
EPS 1Y (TTM)46.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
Revenue 1Y (TTM)16.04%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%9.8%
3.2 Future
Based on estimates for the next years, ACCD will show a very strong growth in Earnings Per Share. The EPS will grow by 21.10% on average per year.
The Revenue is expected to grow by 13.90% on average over the next years. This is quite good.
EPS Next Y29.38%
EPS Next 2Y16.79%
EPS Next 3Y13.89%
EPS Next 5Y21.1%
Revenue Next Year12.54%
Revenue Next 2Y12.6%
Revenue Next 3Y12.75%
Revenue Next 5Y13.9%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ACCD. In the last year negative earnings were reported.
Also next year ACCD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ACCD's earnings are expected to grow with 13.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.79%
EPS Next 3Y13.89%
5. Dividend
5.1 Amount
No dividends for ACCD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACCOLADE INC
NASDAQ:ACCD (1/8/2025, 8:00:00 PM)
After market: 6.82 -0.04 (-0.58%)6.86
+3.51 (+104.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners83.6%
Inst Owner Change0%
Ins Owners3.06%
Ins Owner Change5.65%
Market Cap552.50M
Analysts84
Price Target7.32 (6.71%)
Short Float %3.98%
Short Ratio2.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.82%
Min EPS beat(2)28.86%
Max EPS beat(2)32.78%
EPS beat(4)3
Avg EPS beat(4)15.26%
Min EPS beat(4)-38.53%
Max EPS beat(4)37.91%
EPS beat(8)7
Avg EPS beat(8)14.26%
EPS beat(12)10
Avg EPS beat(12)20.06%
EPS beat(16)11
Avg EPS beat(16)-0.76%
Revenue beat(2)1
Avg Revenue beat(2)1.11%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.48%
Revenue beat(12)9
Avg Revenue beat(12)1.5%
Revenue beat(16)13
Avg Revenue beat(16)1.97%
PT rev (1m)1.28%
PT rev (3m)-9.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.54%
EPS NY rev (1m)1.07%
EPS NY rev (3m)15.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.15%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.25 | ||
| P/FCF | N/A | ||
| P/OCF | 67.5 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.1
OCFY1.48%
SpS5.48
BVpS5.25
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.59% | ||
| ROE | -18.93% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.24% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y5.22%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 20.18% | ||
| Cap/Sales | 2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.72 | ||
| Quick Ratio | 2.72 | ||
| Altman-Z | -0.6 |
F-Score6
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)17.24%
Cap/Depr(5y)23.91%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
EPS Next Y29.38%
EPS Next 2Y16.79%
EPS Next 3Y13.89%
EPS Next 5Y21.1%
Revenue 1Y (TTM)16.04%
Revenue growth 3Y34.47%
Revenue growth 5Y34.31%
Sales Q2Q%9.8%
Revenue Next Year12.54%
Revenue Next 2Y12.6%
Revenue Next 3Y12.75%
Revenue Next 5Y13.9%
EBIT growth 1Y34.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.63%
EBIT Next 3Y36.55%
EBIT Next 5Y25.78%
FCF growth 1Y98.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y114.32%
OCF growth 3YN/A
OCF growth 5YN/A